These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 8866906)
1. Developmental regulation of transforming growth factor-beta 1 responses and vascular smooth muscle growth in spontaneously hypertensive rats. Saltis J; Bobik A J Hypertens; 1995 Dec; 13(12 Pt 1):1441-8. PubMed ID: 8866906 [TBL] [Abstract][Full Text] [Related]
2. Developmentally regulated transforming growth factor-beta 1 action on vascular smooth muscle growth in the SHR. Saltis J; Agrotis A; Kanellakis P; Bobik A Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):149-52. PubMed ID: 8039269 [TBL] [Abstract][Full Text] [Related]
3. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Fukuda N; Hu WY; Kubo A; Endoh M; Kishioka H; Satoh C; Soma M; Izumi Y; Kanmatsuse K Hypertension; 1998 Feb; 31(2):672-7. PubMed ID: 9461239 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats. Sato M; Ohsaki Y; Tobise K Am J Hypertens; 1995 Feb; 8(2):160-6. PubMed ID: 7755944 [TBL] [Abstract][Full Text] [Related]
5. Effect of transforming growth factor-beta 1 on platelet-derived growth factor receptor binding and gene expression in vascular smooth muscle cells from SHR and WKY rats. Agrotis A; Saltis J; Bobik A Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):145-8. PubMed ID: 7518757 [TBL] [Abstract][Full Text] [Related]
6. Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats. Fukuda N; Kubo A; Izumi Y; Soma M; Kanmatsuse K J Hypertens; 1995 Aug; 13(8):831-7. PubMed ID: 8557960 [TBL] [Abstract][Full Text] [Related]
7. Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent. Saltis J; Agrotis A; Bobik A J Hypertens; 1993 Jun; 11(6):629-37. PubMed ID: 8397242 [TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle cell proliferation in SHR and WKY rats: evidence for specific differences in growth inhibitory regulatory mechanisms. Agrotis A; Bray PJ; Saltis J; Bobik A Clin Exp Pharmacol Physiol; 1993 May; 20(5):327-30. PubMed ID: 8324918 [TBL] [Abstract][Full Text] [Related]
9. Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-beta. Nakayama M; Fukuda N; Watanabe Y; Soma M; Hu WY; Kishioka H; Satoh C; Kubo A; Kanmatsuse K J Hypertens; 1999 Oct; 17(10):1421-30. PubMed ID: 10526902 [TBL] [Abstract][Full Text] [Related]
10. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. Satoh C; Fukuda N; Hu WY; Nakayama M; Kishioka H; Kanmatsuse K J Cardiovasc Pharmacol; 2001 Jan; 37(1):108-18. PubMed ID: 11152368 [TBL] [Abstract][Full Text] [Related]
11. Age-dependent alterations in vascular smooth muscle cell responsiveness to platelet-derived growth factor in genetic hypertension. Saltis J; Agrotis A; Bobik A Clin Exp Pharmacol Physiol; 1993 May; 20(5):324-6. PubMed ID: 8324917 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation by transforming growth factor-beta 1 of platelet-derived growth factor-stimulated proliferation of vascular smooth muscle cells from SHR and WKY rats. Saltis J; Agrotis A; Bobik A Clin Exp Pharmacol Physiol; 1992 May; 19(5):396-9. PubMed ID: 1521372 [TBL] [Abstract][Full Text] [Related]
13. Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hu WY; Fukuda N; Su JZ; Kanmatsuse K J Cardiovasc Pharmacol; 2001 Sep; 38(3):450-9. PubMed ID: 11486249 [TBL] [Abstract][Full Text] [Related]
14. Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways. Saltis J; Bobik A J Hypertens; 1992 Jul; 10(7):635-43. PubMed ID: 1321190 [TBL] [Abstract][Full Text] [Related]
15. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats. Fukuda N; Hu WY; Teng J; Chikara S; Nakayama M; Kishioka H; Kanmatsuse K Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats. Bray P; Agrotis A; Bobik A Hypertension; 1998 Apr; 31(4):986-94. PubMed ID: 9535425 [TBL] [Abstract][Full Text] [Related]
17. [Suppression of the exaggerated growth of vascular smooth muscle cells from SHR by antisense oligodeoxynucleotide to TGF beta]. Fukuda N Nihon Rinsho; 1993 Jun; 51(6):1663-7. PubMed ID: 8320846 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 gene activation and growth of smooth muscle from hypertensive rats. Agrotis A; Saltis J; Bobik A Hypertension; 1994 May; 23(5):593-9. PubMed ID: 8175167 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Miyazawa K; Kikuchi S; Fukuyama J; Hamano S; Ujiie A Atherosclerosis; 1995 Dec; 118(2):213-21. PubMed ID: 8770315 [TBL] [Abstract][Full Text] [Related]
20. The angiotensin I-converting enzyme inhibitor, cilazapril inhibits the platelet-derived growth factor B chain expression in glomeruli of spontaneously hypertensive rats. Yamauchi T; Ogura T; Oishi T; Omiya T; Ota Z Ren Physiol Biochem; 1995; 18(5):237-45. PubMed ID: 8869081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]